Log in

NYSEAMERICAN:BVXBovie Medical Stock Price, Forecast & News

$6.48
0.00 (0.00 %)
(As of 12/31/2018)
Add
Compare
Today's Range
$6.35
Now: $6.48
$6.71
50-Day Range N/A
52-Week Range
$2.28
Now: $6.48
$7.70
Volume129,549 shs
Average Volume136,878 shs
Market Capitalization$215.14 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Bovie Medical Corporation, a medical device company, develops, manufactures, and markets electrosurgical devices and technologies, and related medical products used in doctor's offices, surgery centers, and hospitals worldwide. The company provides electrosurgical products, including desiccators, generators, electrodes, electrosurgical pencils, and various ancillary disposable products used during surgical procedures in gynecology, urology, plastic surgery, dermatology, veterinary, and other surgical markets for the cutting and coagulation of tissue. It also offers electrosurgical disposables comprising Resistick II, a proprietary coating applied to stainless steel that resist eschar during surgery; and disposable laparoscopic electrodes for use by physicians in the areas of gynecology, general surgery, and urology. In addition, the company provides battery operated cauteries for precise hemostasis in ophthalmology; nerve locator stimulator primarily used for identifying motor nerves in hand and facial reconstructive surgery; penlights for use in offices; and specialty lighting instruments for use in ophthalmology, as well as distributes specialty lighting instruments for general surgery, hip replacement surgery, and endotracheal tubes placement. Further, it develops J-Plasma, a patented helium-based plasma surgical product, as well as designs, develops, and manufactures electrosurgical equipment by producing equipment for medical device manufacturers through original equipment manufacturing agreements. Bovie Medical Corporation markets its products to distributors under own brands, such as Bovie, IDS, and DERM, as well as under a private label. The company was formerly known as An-Con Genetics Inc. and changed its name to Bovie Medical Corporation in October 1998. Bovie Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
Read More
Bovie Medical logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.46 out of 5 stars


Industry, Sector and Symbol

Stock Exchange NYSEAMERICAN
Industry Medical Instruments & Supplies
Sub-IndustryN/A
SectorMedical
Current SymbolNYSEAMERICAN:BVX
CUSIPN/A
Phone+1-727-3842323

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Market Cap$215.14 million
Next Earnings DateN/A
OptionableOptionable

Receive BVX News and Ratings via Email

Sign-up to receive the latest news and ratings for BVX and its competitors with MarketBeat's FREE daily newsletter.

Bovie Medical (NYSEAMERICAN:BVX) Frequently Asked Questions

How were Bovie Medical's earnings last quarter?

Bovie Medical Co. (NYSEAMERICAN:BVX) released its quarterly earnings results on Thursday, November, 1st. The medical device company reported ($0.01) earnings per share for the quarter, topping the consensus estimate of ($0.09) by $0.08. The medical device company had revenue of $3.67 million for the quarter, compared to analysts' expectations of $3.67 million. The business's quarterly revenue was up 38.5% on a year-over-year basis. During the same period in the previous year, the business posted ($0.09) EPS. View Bovie Medical's earnings history.

Has Bovie Medical been receiving favorable news coverage?

Media coverage about BVX stock has been trending very negative on Sunday, InfoTrie Sentiment Analysis reports. InfoTrie ranks the sentiment of press coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Bovie Medical earned a news sentiment score of -3.2 on InfoTrie's scale. They also gave news stories about the medical device company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the next few days. View the latest news about Bovie Medical.

Who are some of Bovie Medical's key competitors?

What other stocks do shareholders of Bovie Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Bovie Medical investors own include Geron (GERN), AbbVie (ABBV), ENGlobal (ENG), Airgain (AIRG), Liquidity Services (LQDT), NovaBay Pharmaceuticals (NBY), A. H. Belo (AHC), AMAG Pharmaceuticals (AMAG), Antares Pharma (ATRS) and Ceragon Networks (CRNT).

Who are Bovie Medical's key executives?

Bovie Medical's management team includes the following people:
  • Mr. Charles D. Goodwin II, Pres, CEO & Director (Age 52)
  • Mr. Jay D. Ewers, CFO, Treasurer & Sec. (Age 57)
  • Mr. Moshe Citronowicz, Sr. VP (Age 65)
  • Mr. Todd Hornsby, VP & GM of Advanced Energy
  • Mr. Jeffrey Rencher, VP of Sales & Marketing - Surgical Products (Age 51)

What is Bovie Medical's stock symbol?

Bovie Medical trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "BVX."

How do I buy shares of Bovie Medical?

Shares of BVX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Bovie Medical's stock price today?

One share of BVX stock can currently be purchased for approximately $6.48.

How big of a company is Bovie Medical?

Bovie Medical has a market capitalization of $215.14 million.

What is Bovie Medical's official website?

The official website for Bovie Medical is www.boviemedical.com.

How can I contact Bovie Medical?

Bovie Medical's mailing address is 4 Manhattanville Rd Ste 106, PURCHASE, NY 10577-2119, United States. The medical device company can be reached via phone at +1-727-3842323.

This page was last updated on 7/12/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.